Compounds > 2-(2-thenyl)sulfonyl-5-bromopyrimidine
Page last updated: 2024-08-26

2-(2-thenyl)sulfonyl-5-bromopyrimidine and Uterine Cervical Neoplasms

2-(2-thenyl)sulfonyl-5-bromopyrimidine has been researched along with Uterine Cervical Neoplasms in 1 studies

*Uterine Cervical Neoplasms: Tumors or cancer of the UTERINE CERVIX. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dornish, JM; Juul, ME; Oftebro, R; Pettersen, EO; Schwarze, PE1

Other Studies

1 other study(ies) available for 2-(2-thenyl)sulfonyl-5-bromopyrimidine and Uterine Cervical Neoplasms

ArticleYear
Multipolar mitotic cells in the human cell line NHIK 3025 following treatment with the mitotic inhibitor NY 4137.
    Investigational new drugs, 1991, Volume: 9, Issue:1

    Topics: Antineoplastic Agents; Cell Division; Cell Separation; DNA; Female; Flow Cytometry; Humans; Interphase; Mitosis; Proteins; Pyrimidines; Tumor Cells, Cultured; Uterine Cervical Neoplasms

1991